Shek is a physics graduate from Oxford and has an MBA from the London Business School. He has previously worked with investment bankers Morgan Stanley International, Lazard Brothers, JP Morgan, Monitor Group and the Anglo Chinese Group.
Commenting on the appointment, Fintan Walton, PharmaVentures’ chief executive, said: ‘Our Transactions division is currently working with a number of key companies in the life sciences sector, providing a comprehensive M&A and asset divestment service and has recently celebrated successes for a number of clients including UCB, Sanofi, Helsinn and Dow Chemical. Our client portfolio will benefit from this key appointment to the team.’
PharmaVentures appoints senior director in Transactions
Ping Shek will work on key M&A accounts in healthcare
You may also like
Media
Vetter named CDMO of the Year in Finished Dose category at 2026 CDMO Leadership Awards
Vetter has received the Finished Dose award at the 2026 CDMO Leadership Awards, with recognition based on verified sponsor feedback and quantitative performance metrics, as the company advances around €2bn in planned capacity expansions through 2035
Media
Samsung Biologics wins Sustainability Leadership Award at 2026 CDMO Leadership Awards
The company received the Sustainability Leadership Award at the 2026 CDMO Leadership Awards, alongside a Best in Class recognition for Cultural Fit, reflecting its efforts to embed sustainable practices across its operations and client partnerships
Media
FUJIFILM Biotechnologies named Most Innovative CDMO for Biologics at 2026 CDMO Leadership Awards
The brand has received the Most Innovative CDMO (Biologics) award at the 2026 CDMO Leadership Awards, recognised for its sustained investment in science and process development, including the recent launch of its ShunzymeX purification technology platform
Media
CBA releases statement welcoming government's decision to incude biocides in post-Brexit negotiations
Biocides have now been officially included in the scope of negotiations, which the association has called an "important and practical step towards cutting red tape and restoring clarity for businesses," though the "reality is that much more still needs to be done"